pirinixic acid has been researched along with Anti-Glomerular Basement Membrane Disease in 1 studies
pirinixic acid: structure
Anti-Glomerular Basement Membrane Disease: An autoimmune disease of the KIDNEY and the LUNG. It is characterized by the presence of circulating autoantibodies targeting the epitopes in the non-collagenous domains of COLLAGEN TYPE IV in the basement membranes of kidney glomeruli (KIDNEY GLOMERULUS) and lung alveoli (PULMONARY ALVEOLI), and the subsequent destruction of these basement membranes. Clinical features include pulmonary alveolar hemorrhage and glomerulonephritis.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, DC | 1 |
| Frkanec, JT | 1 |
| Cromwell, J | 1 |
| Clopton, P | 1 |
| Cunard, R | 1 |
1 other study available for pirinixic acid and Anti-Glomerular Basement Membrane Disease
| Article | Year |
|---|---|
WY14,643, a PPARalpha ligand, attenuates expression of anti-glomerular basement membrane disease.
Topics: Animals; Anti-Glomerular Basement Membrane Disease; Chemokine CCL2; Cytokines; Disease Progression; | 2007 |